Cargando…
Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
BACKGROUND AND PURPOSE: The detection of α-synuclein in the body fluids of patients with synucleinopathy has yielded promising but inconclusive results, in part because of conformational changes of α-synuclein in response to environmental conditions. The aim of this study was to determine the feasib...
Autores principales: | Park, Min Jeong, Cheon, Sang-Myung, Bae, Hye-Ran, Kim, Sang-Ho, Kim, Jae Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259496/ https://www.ncbi.nlm.nih.gov/pubmed/22259618 http://dx.doi.org/10.3988/jcn.2011.7.4.215 |
Ejemplares similares
-
Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
por: Aasly, Jan O., et al.
Publicado: (2014) -
Orthostatic Hypotension in Drug-Naïve Patients with Parkinson’s Disease
por: Bae, Hyo-Jin, et al.
Publicado: (2011) -
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2014) -
The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020) -
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
por: Paslawski, Wojciech, et al.
Publicado: (2019)